Neurostimulation startup Neuros Medical has received regulatory approval to begin a pilot clinical trial of its device that blocks pain experienced by amputees.Receiving Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration is an important next step for Cleveland-area Neuros. A successful pilot study could clear the way for a pivotal clinical [...]

Neurostimulation company Neuros Medical is looking to collect a $3.5 million round of investment that it would use to launch a pilot study of its pain-relief device.After earlier this year completing the first successful in-man feasibility study of its pain-blocking device, Willoughby, Ohio-based Neuros plans to conduct a pilot clinical trial that follows a larger [...]

Neurotechnology startup Neuros Medical reported encouraging results from the first in-human study of its device that blocks pain for amputation patients.The Willoughby, Ohio, company said that four of five patients in the study reported that Neuros’ device reduced their pain to “zero,” according to a statement from the company.“My pain was gone, something I have [...]

Neuros Medical announced positive early results in the first-ever in-human feasibility study of its pain-blocking device.

Cleveland Clinic neuromodulation spinoff Intelect Medical may have stealthily exited Cleveland to set up shop in Boston, but the company’s recent $78 million sale to Boston Scientific (NYSE: BSX) highlights Northeast Ohio’s growing strength in neurotechnology. Here’s a brief overview of the key players in Northeast Ohio’s rising neurotechnology industry.

Neuros Medical Inc. has added a medical device industry veteran to its board of directors.Scott Drees joins the board as an independent director, according to a statement from Neuros. The Willoughby, Ohio company is developing a neurostimulation device that uses a pacemaker-sized generator and an electrode to stimulate nerves to block [...]

Neuros Medical Inc. plans to double — maybe even triple — its employment over the coming year as it uses a $1.5 million U.S. Department of Defense grant to speed development of its neurostimulation device to block chronic pain.The Willoughby, Ohio, company is developing a device that uses a pacemaker-sized generator and an electrode [...]

Queen City Angels invested in seven life sciences companies and one health information technology company last year, according to its 2009 annual operating report (pdf).The group of accredited investors finished the year with 12 investments, which included three IT companies and one company specializing in advanced materials.In addition, the angel group created a $4 million [...]

Neuros Medical Inc. has chosen Battelle to help develop its neurostimulation device to block chronic pain. Neuros Medical is developing a “nerve block” system that stimulates nerves to block pain.

Fresh from its first round of fundraising, neurostimulation device developer Neuros Medical Inc. has hired a chief technology officer and appointed a board of advisers.